Ebook Diagnostic imaging chest (2nd edition): Part 2
➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạmNội dung chi tiết: Ebook Diagnostic imaging chest (2nd edition): Part 2
Ebook Diagnostic imaging chest (2nd edition): Part 2
Diagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2iderLipoid pneumonia in patients with pulmonary nodule, mass, or consolidation with intrinsic fat attenuation or "crazy-paving" pattern on CTSELECTED REFERENCES1.Betancourt SL et al: Lipoid pneumonia: spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol. 194(l):103-9, 20102.Franqu Ebook Diagnostic imaging chest (2nd edition): Part 2et T et al: The crazy-paving pattern in exogenous lipoid pneumonia: CT-pathologic correlation. AIR Am J Roentgenol. 170(2):315-7,1998Section 7 - ConneEbook Diagnostic imaging chest (2nd edition): Part 2
ctive Tissue Disorders, Immunological Diseases, and Vasculitis Introduction and OverviewApproach to Connective Tissue Disorders, Immunological DiseaseDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2pproach to Connective Tissue Disorders, Immunological Diseases, and Vasculitis Approach to Connective Tissue Disorders, Immunological Diseases, and Vasculitis Gerald F. Abbott. MD Imaging ModalitiesFor patients with connective tissue disorders, immunological diseases, and vasculitis who have symptom Ebook Diagnostic imaging chest (2nd edition): Part 2s referable to the thorax, the imaging evaluation typically begins with chest radiography but often requires CT/HRCT studies for accurate detection anEbook Diagnostic imaging chest (2nd edition): Part 2
d characterization of pleuropulmonary abnormalities. In some cases, the pleuropulmonary imaging findings of these disorders are the initial manifestatDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2led collagen vascular diseases) comprise a group of autoimmune disorders characterized by damage to connective tissue components at various anatomic locations in the body. These include rheumatoid arthritis, scleroderma, mixed connective tissue disorder, polymyositis and dermatomyositis, systemic lu Ebook Diagnostic imaging chest (2nd edition): Part 2pus erythematosus, Sjogren syndrome, and ankylosing spondylitis. These disease processes may be associated with focal or diffuse pulmonary abnormalitiEbook Diagnostic imaging chest (2nd edition): Part 2
es. Diffuse infiltrative pulmonary disease is most commonly detected in patients with rheumatoid arthritis and in those with progressive systemic scleDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2able from usual interstitial pneumonia (UIP) in its clinical, radiographic, and CT/HRCT manifestations. However, ground-glass opacity is often a predominant CT/HRCT finding in patients with lung disease associated v/ith connective tissue disorders, typically with finer reticulation and less frequent Ebook Diagnostic imaging chest (2nd edition): Part 2 honeycombing than that which characterizes UIP and idiopathic pulmonary fibrosis (IPF). Connective tissue diseases are often associated with pathologEbook Diagnostic imaging chest (2nd edition): Part 2
ic abnormalities other than DIP. including nonspecific interstitial pneumonia (NSIP), bronchiolitis obliterans, bronchiectasis, lymphoid interstitial Diagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2itial lung disease, which may progress to end-stage fibrosis and honeycomb lung, they are also at increased risk for the development of primary lung cancer. Thus, radiologists must regard any new pulmonary nodule or mass in such patients v/ith a high index of suspicion for malignancy and should aggr Ebook Diagnostic imaging chest (2nd edition): Part 2essively pursue a definitive diagnosis in these cases.Immunocompromised PatientsIn recent decades, several factors have led to an increased number ofEbook Diagnostic imaging chest (2nd edition): Part 2
immunocompromised patients, including the widespread use of ablative chemotherapy in the management of patients with cancer, an increase in the frequeDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2promised patients should always prompt consideration of infection as an important differential diagnostic possibility. However, many other disease processes that mimic infection must also be778Diagnostic Imaging Chestexcluded, including cytotoxic and noncytotoxic drug reactions, interstitial lung di Ebook Diagnostic imaging chest (2nd edition): Part 2seases, lymphoproliferative disorders, and malignant neoplasms.The chest radiograph IS an important initial imaging modality in the evaluation of sympEbook Diagnostic imaging chest (2nd edition): Part 2
tomatic immunocompromised patients, but it may be normal in 10% of patients with pulmonary complications. Chest CT and HRCT provide improved accuracy Diagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2epidemiological information, imaging findings may help to narrow the differential diagnostic possibilities and determine the next best steps in the diagnostic process. Comparison with previous chest imaging studies is critical to recognize new abnormalities and determine the temporal sequence of the Ebook Diagnostic imaging chest (2nd edition): Part 2ir progression.The presence or absence of associated findings such as lymphadenopathy and pleural effusion may help to narrow the list of differentialEbook Diagnostic imaging chest (2nd edition): Part 2
diagnostic possibilities. Specific clinical and imaging features may be important clues to the diagnosis. For example, lung nodules, masses, and consDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2ility. In fact, management decisions in the treatment of opportunistic infections in immunocompromised patients are frequently made based on imaging abnormalities and may not require microbiologic confirmation. On the other hand, the finding of ground-glass opacity in patients with HIV/AIDS is highl Ebook Diagnostic imaging chest (2nd edition): Part 2y suggestive of Pneumocystis jiroveci pneumonia (PCP). Pulmonary Hemorrhage and VasculitisPulmonary vasculitis syndromes include several disease entitEbook Diagnostic imaging chest (2nd edition): Part 2
ies, some of which frequently affect the lung le.g., Wegener granulomatosis, Churg-Strauss vasculitis, and microscopic polyangiitis). Pulmonary vasculDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2ry vasculitis syndromes are chnkopathologic entities: their diagnosis is based not solely on pathologic findings, but rather on a correlation among dinteal, imaging, and pathologic features.Clinical settings in which pulmonary vasculitis may occur are variable and include diffuse pulmonary hemorrhag Ebook Diagnostic imaging chest (2nd edition): Part 2e, pulmonary renal syndromes, pulmonary nodular and/or cavitary disease, and upper airway lesions. When patients present with pulmonary hemorrhage, coEbook Diagnostic imaging chest (2nd edition): Part 2
rroborated by imaging findings and clinical testing, pulmonary vasculitis should be considered as a differential diagnostic possibility, including theDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsi Ebook Diagnostic imaging chest (2nd edition): Part 2 References1. Hansell DM et al: Idiopathic interstitial pneumoniasand immunologic disease of the lungs. In Imaging of Diseases of the Chest. St. Louis: Mosby. 608-39, 2010p.7:3Image Gallery(Left) HRCT of a patient With scleroderma shows esophageal dilatation and posterior subpleural ground-glassSand Ebook Diagnostic imaging chest (2nd edition): Part 2 reticular opacities Connective tissue diseases may exhibit findings indistinguishable from UIP. However, ground-glass opacity is typically the predomEbook Diagnostic imaging chest (2nd edition): Part 2
inant finding in patients with associated NSIP. (Right) HRCT of a patient with scleroderma shows pulmonary fibrosis and honeycombing . A focal nodularDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsiDiagnostic Imaging ChestTreatmentDiscontinuation of use of lipoid agentDiagnosisTransthoracic needle biopsy may be diagnosticDIAGNOSTIC CHECKLISTConsiGọi ngay
Chat zalo
Facebook